Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Inducement Award Plan Inducement Award Plan [Member] Inducement Award Plan Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Net loss - diluted Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Discount rate Lessee, Operating Lease, Discount Rate Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Number of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Conversion of stock, shares issued (in shares) Conversion of stock, issuance (in shares) Conversion of Stock, Shares Issued Segment Reporting [Abstract] Common stock—$0.001 par value; 200,000,000 shares authorized at September 30, 2026 and December 31, 2025; 53,923,083 and 18,512,757 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Cash paid related to withholding shares to satisfy RSU tax withholding obligations Payment, Tax Withholding, Share-Based Payment Arrangement Compensation and benefits Employee-related Liabilities, Current Restatement Determination Date Restatement Determination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Vesting of Restricted Stock Units net of shares withheld for taxes (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Licensed product expiration term Contract With Customer, License Agreement Expiration Term Contract With Customer, License Agreement Expiration Term Number of shares available under warrant (in shares) Number of common shares underlying warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Measurement Frequency [Axis] Measurement Frequency [Axis] Weighted average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price U.S. Treasury securities US Treasury and Government [Member] Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Shares converted (in shares) Conversion of Stock, Shares Converted Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Class of Warrant or Right [Table] Class of Warrant or Right [Table] Initial valuation of warrant liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Change in fair value of warrant liability Fair Value Adjustment of Warrants Period after public launch to terminate agreement Royalty Agreement, Period After Public Launch to Terminate Agreement Royalty Agreement, Period After Public Launch to Terminate Agreement Schedule of Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale [Table Text Block] Leases [Abstract] Leases [Abstract] Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] 2016 Fourth Amended Plan 2016 Fourth Amended Plan [Member] 2016 Fourth Amended Plan Revenue recognized from milestones to date Contract With Customer, Revenue Recognized to Date From Milestone Payments Contract With Customer, Revenue Recognized to Date From Milestone Payments Change in fair value of derivative liability Change in fair value of derivative liability Fair Value Adjustment of Derivative Liability Fair Value Adjustment of Derivative Liability Expense (Income) AVTX-007 AVTX-007 [Member] AVTX-007 Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Series C preferred stock Series C Preferred Stock (as-converted to common stock) Series C Preferred Stock [Member] PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Assets Assets, Fair Value Disclosure [Abstract] Asset Acquisition [Axis] Asset Acquisition [Axis] Unvested RSUs, beginning balance (in shares) Unvested RSUs, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted average common shares outstanding, basic (in shares) Weighted average shares, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Accretion of available-for-sale investments, net Accretion (Amortization) of Discounts and Premiums, Investments Long-term investments Long-Term Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Lilly License Agreement Lilly License Agreement [Member] Lilly License Agreement Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current ES ES [Member] ES [Member] ATM Program ATM Program [Member] ATM Program Maryland MARYLAND Entity Address, City or Town Entity Address, City or Town Milestone equity payment (as a percent) Milestone Equity Payment Percentage Milestone Equity Payment Percentage Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Title of Individual [Domain] Title and Position [Domain] Milestone [Domain] Milestone [Domain] [Domain] for Milestone [Axis] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net loss - basic Net Income (Loss) Available to Common Stockholders, Basic Proceeds from issuance of common stock under employee stock purchase plan, net of cash paid related to withholding shares to satisfy tax withholding obligations Proceeds from Stock Plans Level 2 Fair Value, Inputs, Level 2 [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Other Other Expenses AVTX-301 Out-License AVTX-301 Out-License [Member] AVTX-301 Out-License Milestone Two Milestone Two [Member] Milestone Two [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Cancelled (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Cancelled In Period, Weighted Average Exercise Price Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Cancelled In Period, Weighted Average Exercise Price Issuance of common stock pursuant to AlmataBio Milestone Buyout Option Issuance Of Common Stock Pursuant To Milestone Buyout Option Issuance Of Common Stock Pursuant To Milestone Buyout Option Conversion ratio Stockholders' Equity Note, Conversion Ratio Stockholders' Equity Note, Conversion Ratio Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Property and equipment, net Property, Plant and Equipment and Operating Lease Right-of-use Asset, After Accumulated Depreciation and Amortization Property, Plant and Equipment and Operating Lease Right-of-use Asset, After Accumulated Depreciation and Amortization Grantee Status [Axis] Grantee Status [Axis] Schedule of Research and Development Expenses Segment Reporting [Table Text Block] Collaborative agreement, milestone payment Collaborative Agreement, Milestone Payment Collaborative Agreement, Milestone Payment Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Changes in the Fair Value of the Level 3 Valuation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Almata Transaction And March 2024 Financing Almata Transaction And March 2024 Financing [Member] Almata Transaction And March 2024 Financing Schedule of Operating Lease Maturities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental disclosures of non-cash activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Document Period End Date Document Period End Date Changes in assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Balance at the beginning (in shares) Balance at the end (in shares) Preferred Stock, Shares Outstanding Asset acquisition consideration transferred, liabilities Asset Acquisition Consideration Transferred, Liabilities Asset Acquisition Consideration Transferred, Liabilities Basic loss per share: Earnings Per Share, Basic [Abstract] Capital Structure Equity [Text Block] Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Temporary equity, shares outstanding (in shares) Balance at the beginning (in shares) Balance at the end (in shares) Temporary Equity, Shares Outstanding Security Exchange Name Security Exchange Name Gross Unrealized Gains Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Unrealized Gains Excluding Accrued Interest Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Unrealized Gains Excluding Accrued Interest Maximum annual amount of fair market value of the company's common stock that a participant may accrue the rights to purchase Share Based Compensation Arrangement by Share Based Payment Award Fair Value Amount of Outstanding Stock Maximum Share Based Compensation Arrangement by Share Based Payment Award Fair Value Amount of Outstanding Stock Maximum AUG Therapeutics, LLC AUG Therapeutics, LLC [Member] AUG Therapeutics, LLC Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Number of classes of stock authorized to issue Number of Class of Stock Authorized The number of classes of stock permitted to be issued by an entity's charter and bylaws. Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Accrued expenses and other current liabilities Lease liability, current Operating Lease, Liability, Current Unrealized loss position for greater than twelve months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Comprehensive loss: Statement of Comprehensive Income [Abstract] Pennsylvania PENNSYLVANIA Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Marketable debt securities Debt Securities, Available-for-Sale, Excluding Accrued Interest Geographical [Domain] Geographical [Domain] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Compensation not yet recognized Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Automatic increase to shares authorized of outstanding stock at end of preceding year (as a percent) Share Based Compensation Arrangement by Share Based Payment Award Automatic Increase to Shares Authorized as Percentage of Outstanding Stock at End of Preceding Year Share Based Compensation Arrangement by Share Based Payment Award Automatic Increase to Shares Authorized as Percentage of Outstanding Stock at End of Preceding Year Alto Alto [Member] Alto [Member] Increase in number of shares reserved for issuance (in shares) Share Based Compensation Arrangement by Share Based Payment Award Number of Shares Authorized Increase Represents the increase in the number of shares reserved for issuance under the incentive plan. Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Contingent milestone payment Contingent Milestone Payment Contingent Milestone Payment Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Unrealized (loss) gain on investments, net OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Cancelled, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Cancelled in Period, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Cancelled in Period, Intrinsic Value Diluted loss per share: Earnings Per Share, Diluted [Abstract] Astellas Pharma, Inc. (Astellas) Astellas Pharma, Inc. (Astellas) [Member] Astellas Pharma, Inc. (Astellas) [Member] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] AVTX-009 Lilly License Agreement AVTX-009 Lilly License Agreement [Member] AVTX-009 Lilly License Agreement Issuance of common stock (in shares) Shares, Issued Compensation Amount Outstanding Recovery Compensation Amount Milestone payments Collaborative Arrangement, Rights and Obligations, Milestone Payments Collaborative Arrangement, Rights and Obligations, Milestone Payments Measurement Input, Probability Of Success Measurement Input, Probability Of Success [Member] Measurement Input, Probability Of Success Individual: Individual [Axis] Clinical expenses Clinical Expenses Clinical Expenses Weighted average common shares outstanding, diluted (in shares) Weighted average shares, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent License agreement royalties (as a percent) Collaborative Arrangement, License Rights Royalty Percentage Collaborative Arrangement, License Rights Royalty Percentage U.S. Treasury securities US Treasury Securities [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Less implied interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Kyowa Kirin Co., Ltd. (KKC) Kyowa Kirin Co., Ltd. (KKC) [Member] Kyowa Kirin Co., Ltd. (KKC) [Member] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Christopher Sullivan [Member] Christopher Sullivan Award Timing Predetermined Award Timing Predetermined [Flag] Exercised, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Milestone [Axis] Milestone [Axis] Milestone [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Grantee Status [Domain] Grantee Status [Domain] Total lease payments Lessee, Operating Lease, Liability, to be Paid Unvested RSUs, beginning of period (in dollars per share) Unvested RSUs, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table] Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table] Contingent consideration Asset Acquisition, Contingent Consideration, Liability All Executive Categories All Executive Categories [Member] Decrease in lease liability Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Common Stock Warrants Class of Warrant or Right [Line Items] Plan Name [Domain] Plan Name [Domain] Redemption of Series D Preferred Stock and Series E Preferred Stock (in shares) Temporary Equity, Shares, Conversion of Convertible Securities Temporary Equity, Shares, Conversion of Convertible Securities Asset Acquisition [Domain] Asset Acquisition [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Balance, beginning of period (in dollars per share) Balance, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Employee Stock Purchase Plan (ESPP) Employee Stock Purchase Plan (ESPP) [Member] Employee Stock Purchase Plan (ESPP) Right-of-use assets Operating Lease, Right-of-Use Asset Proceeds from issuance of common stock pursuant to ATM Program, net Proceeds From Venture Debt Financing Agreement Proceeds From Venture Debt Financing Agreement Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Schedule of the Computation of Basic and Diluted Net Loss Per Share of Common Stock Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Milestone cash payment (as a percent) Milestone Cash Payment Percentage Milestone Cash Payment Percentage Segments Segment Reporting [Text Block] Investments Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Contingent milestone upfront payment (as a percent) Contingent Milestone Upfront Payment Percentage Contingent Milestone Upfront Payment Percentage Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Collaborative arrangement, royalty term Collaborative Arrangement, Royalty Term Collaborative Arrangement, Royalty Term Weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Building Building [Member] Net present value of royalty payments (as a percent) Royalty Agreement, Buyout Option, Percentage of Net Present Value of Royalty Payments Royalty Agreement, Buyout Option, Percentage of Net Present Value of Royalty Payments Exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Exercise Price Award Exercise Price Vesting of Restricted Stock Units net of shares withheld for taxes Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Recurring Basis Fair Value, Recurring [Member] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items] Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items] Series E Preferred Stock Series E Preferred Stock [Member] Annual base rent Lessee, Operating Lease, Liability, Annual Base Rent Lessee, Operating Lease, Liability, Annual Base Rent Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Net proceeds Sale of Stock, Consideration Received on Transaction Total operating expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Proceeds from issuance or sale of equity Proceeds from Issuance or Sale of Equity Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ equity Balance at the beginning Balance at the end Equity, Attributable to Parent Total other income (expense), net Nonoperating Income (Expense) Restructuring Type [Axis] Restructuring Type [Axis] Upfront license fee Collaborative Arrangement, Rights And Obligations, Upfront Fee Collaborative Arrangement, Rights And Obligations, Upfront Fee Milestone Three Milestone Three [Member] Milestone Three Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total operating lease liabilities Total Operating Lease, Liability Insider Trading Policies and Procedures [Line Items] Outstanding (in shares) Balance, beginning of period (in shares) Balance, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Cumulative expense recognized to date Collaborative Arrangement, Rights and Obligations, Cumulative Milestone Payment Expense Recognized to Date Collaborative Arrangement, Rights and Obligations, Cumulative Milestone Payment Expense Recognized to Date Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Performance Stock Units Performance Shares Performance Shares [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Deferred taxes Deferred Income Tax Expense (Benefit) Type of Restructuring [Domain] Type of Restructuring [Domain] Gross Unrealized Losses Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Unrealized Losses Excluding Accrued Interest Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Unrealized Losses Excluding Accrued Interest Interest income, net Interest Income (Expense), Nonoperating Cancelled (in dollars per share) Share-based Compensation Arrangement By Share-based Payment Award, Options, Nonvested Options Cancelled, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement By Share-based Payment Award, Options, Nonvested Options Cancelled, Weighted Average Grant Date Fair Value Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of operating segments Number of Operating Segments Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted Stock Units Restricted Stock Units (RSUs) [Member] Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Weighted Shares Outstanding Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments for legal settlements Payments for Legal Settlements AVTX-002 KKC License Agreement AVTX-002 KKC License Agreement [Member] AVTX-002 KKC License Agreement Income Statement [Abstract] Income Statement [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Shares purchased through employee stock purchase plan, net of shares withheld for taxes (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Fair Value Assumptions for Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Fair value of options vested in period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Number of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code Accumulated other comprehensive loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Name Forgone Recovery, Individual Name Period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Garry Neil, M.D., Trading Arrangement Adoption [Member] Garry Neil, M.D., Trading Arrangement Adoption Statement [Line Items] Statement [Line Items] Number of institutional investors in private placement Number Of Institutional Investors In Private Placement Number Of Institutional Investors In Private Placement Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Shares of common stock for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Stock-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Shares purchased through employee stock purchase plan, net of shares withheld for taxes Stock Issued During Period, Value, Employee Stock Purchase Plan Business Nature of Operations [Text Block] Issuance of common stock and pre-funded warrants in underwritten public offering, net (in shares) Issuance of common stock from exercise of stock options (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Garry Neil, M.D., Trading Arrangement Termination [Member] Garry Neil, M.D., Trading Arrangement Termination Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Number of additional shares allowable under the plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Allowable Under The Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Allowable Under The Plan Total stock-based compensation Stock-based compensation expense Share-Based Payment Arrangement, Expense Other long-term liabilities Other Liabilities, Noncurrent Goodwill Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Issuance of common stock from exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Garry Neil, M.D. [Member] Garry Neil, M.D. Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value AVTX-006 Astellas License Agreement AVTX-006 Astellas License Agreement [Member] AVTX-006 Astellas License Agreement Subsequent Event Type [Domain] Subsequent Event Type [Domain] Other long-term liabilities Operating Lease, Liability, Noncurrent Accumulated deficit Retained Earnings [Member] Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Money market funds Money Market Funds [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Balance at the beginning (in shares) Balance at the end (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Christopher Sullivan Trading Arrangement, Restricted Stock Units [Member] Christopher Sullivan Trading Arrangement, Restricted Stock Units Net loss per share of common stock - diluted (in dollars per share) Diluted, net loss per share (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Collaborative arrangement, trading day Collaborative Arrangement, Trading Day Collaborative Arrangement, Trading Day Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Liabilities Liabilities, Fair Value Disclosure [Abstract] Purchase Agreement Purchase Agreement [Member] Purchase Agreement Termination fee Lessee, Operating Lease, Termination Fee Lessee, Operating Lease, Termination Fee Research and development expense Research and development expense Research and Development Expense Adjustments to reconcile net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Temporary equity, par value per share (in dollars per share) Temporary Equity, Par or Stated Value Per Share Share-Based Payment Arrangement [Abstract] Proceeds from sale of common stock and pre-funded warrants in an underwritten public offering, gross Proceeds from Issuance of Common Stock And Pre-Funded Warrants In An Underwritten Public Offering, Gross Proceeds from Issuance of Common Stock And Pre-Funded Warrants In An Underwritten Public Offering, Gross Common Stock Warrants Common Stock Warrants [Member] Common Stock Warrants Financial Instruments [Domain] Financial Instruments [Domain] Contract Termination Contract Termination [Member] Issuance of common stock from exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Purchases of investments Payments to Acquire Short-Term Investments Issuance of common stock and pre-funded warrants in underwritten public offering, net Issuance of common stock in cash Stock Issued During Period, Value, New Issues Over-Allotment Option Over-Allotment Option [Member] Transaction costs paid pursuant to sale of common stock and pre-funded warrants in an underwritten public offering Payments for Repurchase of Initial Public Offering Preferred Stock Preferred Stock [Member] Lease liability, net Increase (Decrease) in Lease Liability Increase (Decrease) in Lease Liability Schedule of Restricted Stock Shares Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Unrealized gain on investments, net Adjustments To Additional Paid In Capital, Unrealized Gain (Loss) On Investments Adjustments To Additional Paid In Capital, Unrealized Gain (Loss) On Investments Segment Reporting [Table] Segment Reporting [Table] Common stock remaining for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant AVTX-006 AVTX-006 [Member] AVTX-006 Maximum portion of earning an employee may contribute to the ESPP Plan (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Title of Individual [Axis] Title and Position [Axis] Sale of Stock [Axis] Sale of Stock [Axis] Royalty payments period Collaborative Arrangement, Rights and Obligations, Royalty Payments Period Collaborative Arrangement, Rights and Obligations, Royalty Payments Period Investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Weighted average remaining contractual term/ Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Schedule of Components of Lease Expense Lease, Cost [Table Text Block] Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Unrealized loss position for less than twelve months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Beginning balance Ending balance Contingent consideration Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) AlmataBio Transaction AlmataBio Transaction [Member] AlmataBio Transaction Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Maximum aggregate milestone payment Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments Fair Value Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Excluding Accrued Interest Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Excluding Accrued Interest Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Equity Option Equity Option [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Common Stock Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Common Stock Warrants Expiration June 2031 Common Stock Warrants Expiration June 2031 [Member] Common Stock Warrants Expiration June 2031 [Member] CMC expenses Chemistry, Manufacturing And Control Expenses Chemistry, Manufacturing And Control Expenses Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities and Other Current Liabilities [Table Text Block] Tabular disclosure of the components of accrued expenses and other current liabilities. Schedule of Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted average exercise price per share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Royalty payment Accrued Royalties, Current Equity Components [Axis] Equity Components [Axis] Product and Service [Domain] Product and Service [Domain] Stock Conversion Description [Axis] Stock Conversion Description [Axis] Entity Interactive Data Current Entity Interactive Data Current Annual share reserve increase Share Based Compensation Arrangement by Share Based Payment Award Share Reserve Increase as Percent The percent, applied to total number of outstanding shares of common stock on the last trading day in December of the prior year, by which the share reserve automatically increases on the first day of January of each calendar year beginning in 2016. Deferred tax liability, net Deferred Income Tax Liabilities, Net Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent AVTX-501 And AVTX-007 AVTX-501 And AVTX-007 [Member] AVTX-501 And AVTX-007 Number of shares of capital stock authorized to issue (in shares) Capital Stock Shares Authorized The maximum number of capital stock, including common stock and preferred stock, solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Termination Date Trading Arrangement Termination Date ES Therapeutics, LLC ES Therapeutics [Member] ES Therapeutics Settlement of contingent consideration Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Exercised (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Exercised, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Exercised, Weighted Average Grant Date Fair Value Award expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Significant Accounting Policies Significant Accounting Policies [Text Block] CHOP License Agreement CHOP License Agreement [Member] CHOP License Agreement Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Temporary equity, liquidation preference (in dollars per share) Temporary Equity, Liquidation Preference Per Share Local Phone Number Local Phone Number Maximum proceeds from milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Contingent consideration paid pursuant to AlmataBio Transaction Payment for Contingent Consideration Liability, Operating Activities Temporary equity, shares authorized (in shares) Temporary Equity, Shares Authorized Nonclinical expenses Nonclinical Expenses Nonclinical Expenses Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Royalty obligation Accrued Royalties Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Expected term of option (in years) Warrants and Rights Outstanding, Term Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Maximum potential payments Maximum Potential Payments Maximum Potential Payments License and milestones Accrued License And Milestones, Current Accrued License And Milestones, Current Executive Category: Executive Category [Axis] Issuance of common stock pursuant to AlmataBio Milestone Buyout Option Stock Issued During Period, Value, Purchase of Assets Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Warrants on common stock Warrant Common Stock [Member] Represents the information pertaining to warrant common stock. Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Counterparty Name [Axis] Counterparty Name [Axis] Liabilities, mezzanine equity and stockholders’ equity Liabilities and Equity [Abstract] Other Commitments [Table] Other Commitments [Table] Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Temporary equity, values issued Balance at the beginning Balance at the end Temporary Equity, Carrying Amount, Attributable to Parent Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount October 1, 2026 through December 31, 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Level 3 Fair Value, Inputs, Level 3 [Member] Balance, beginning of period (in dollars per share) Balance, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Measurement Input, Sales Forecast Peak Measurement Input, Sales Forecast Peak [Member] Measurement Input, Sales Forecast Peak Closing stock price (in dollars per share) Share Price Lease term Lessee, Operating Lease, Term of Contract PEO Name PEO Name Expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Expired, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Expired, Weighted Average Grant Date Fair Value Geographical [Axis] Geographical [Axis] Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Temporary equity, shares issued (in shares) Temporary Equity, Shares Issued Cash and cash equivalents and investments Cash, Cash Equivalents, and Short-Term Investments Property, Plant and Equipment, Type [Axis] Long-Lived Asset, Class [Axis] License fee Collaborative Arrangement Rights And Obligations License Fee Collaborative Arrangement Rights And Obligations License Fee Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Liability Class [Axis] Liability Class [Axis] Other Commitments [Line Items] Other Commitments [Line Items] Conversion Of Convertible Preferred Stock Conversion Of Convertible Preferred Stock [Member] Conversion Of Convertible Preferred Stock License and milestone expenses License And Milestone Expenses License And Milestone Expenses Prefunded Warrant Prefunded Warrant [Member] Prefunded Warrant Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Shares available to vest (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Available For Vesting, Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Available For Vesting, Shares Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Preferred stock ownership (as a percent) Preferred Stock Ownership Percentage Preferred Stock Ownership Percentage General and administrative Accrued General And Administrative Expenses, Current Carrying value as of the balance sheet date of obligations incurred and payable for general and administrative expenses. Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Restricted cash, current portion Restricted cash, current Restricted Cash and Cash Equivalent, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Research and development Accrued Research And Development Expenses, Current Carrying value as of the balance sheet date of obligations incurred and payable for research and development. Employee Share-Based Payment Arrangement, Employee [Member] Measurement Frequency [Domain] Measurement Frequency [Domain] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Salaries, benefits and related costs Labor and Related Expense Purchase price of common stock (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Annual base rent Lessee, Operating Lease, Annual Base Rent Lessee, Operating Lease, Annual Base Rent Issuance of stock in exchange for retirement (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Schedule of Assets and Liabilities Lessee Assets and Liabilities Lessee [Table Text Block] Assets and Liabilities Lessee [Table Text Block] Contingent consideration Asset Acquisition, Consideration Transferred, Contingent Consideration Leases Lessee, Operating Leases [Text Block] Net loss per share of common stock - basic (in dollars per share) Basic, net loss per share (in dollars per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Amortized Cost Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Amortized Cost, Excluding Accrued Interest Cash, Cash Equivalents And Debt Securities, Available-For-Sale, Amortized Cost, Excluding Accrued Interest Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Change in fair value of contingent consideration Change in fair value of contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common stock Common Stock [Member] Expected stock price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Operating lease cost Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Expected annual dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Cancelled (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Cancelled In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Cancelled In Period Series C-1 preferred Stock Series C-1 Preferred Stock (as-convertible to common stock) Series C-1 Preferred Stock [Member] Series C-1 Preferred Stock Jennifer Riley [Member] Jennifer Riley Performance metric (as a percent) Share-Based Compensation, Performance Metric Share-Based Compensation, Performance Metric Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities, mezzanine equity and stockholders’ equity Liabilities and Equity Derivative liability, non-current Derivative Liability, Noncurrent AVTX-406 License Assignment AVTX-406 License Assignment [Member] AVTX-406 License Assignment Preferred Stock, convertible, shares issuable in common stock (in shares) Preferred Stock, Convertible, Shares Issuable Stock options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Weighted average grant date fair value per share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Plan Name [Axis] Plan Name [Axis] Derivative liability, measurement input Derivative Liability, Measurement Input Series D Preferred Stock Series D Preferred Stock [Member] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Restricted cash, net of current portion Restricted cash, non-current Restricted Cash and Cash Equivalent, Noncurrent Remaining lease team Lessee Operating Lease Remaining Lease Team Lessee Operating Lease Remaining Lease Team Name Awards Close in Time to MNPI Disclosures, Individual Name Options vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Contingent consideration Contingent Consideration [Member] Contingent Consideration Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative General and Administrative Expense Property, Plant and Equipment, Type [Domain] Long-Lived Asset, Class [Domain] AVTX-800 Series Asset Sale AVTX-800 Series Asset Sale [Member] AVTX-800 Series Asset Sale Sale of stock (in dollars per share) Sale of Stock, Price Per Share Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Issuance of stock in exchange for retirement Stock Issued During Period, Value, Conversion of Convertible Securities Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Accrued Liabilities and Other Liabilities [Abstract] Accrued Liabilities and Other Liabilities [Abstract] Series C Preferred Stock—$0.001 par value; 3,359 and 34,326 shares of Series C Preferred Stock authorized at September 30, 2026 and December 31, 2025, respectively; 3,359 and 18,792 shares of Series C Preferred Stock issued and outstanding at September 30, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued AVTX-611 AVTX-611 [Member] AVTX-611 Adjustment to Compensation: Adjustment to Compensation [Axis] Accrued expenses and other current liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Derivative liability Derivative Financial Instruments, Liabilities [Member] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Royalty agreement, payment received Royalty Agreement, Payment Received Royalty Agreement, Payment Received Cash payments to acquire assets Payments to Acquire Productive Assets Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total financial assets Assets, Fair Value Disclosure Investments Investment, Policy [Policy Text Block] Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Director Director [Member] Short-term investments Short-Term Investments Reportable Segment Reportable Segment [Member] Reportable Segment Name Trading Arrangement, Individual Name Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Measurement Input, Expected Term Measurement Input, Expected Term [Member] Derivative liability, measurement input, term Derivative Liability, Measurement Input, Term Derivative Liability, Measurement Input, Term Operating lease, expense Operating Lease, Expense Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Company Selected Measure Amount Company Selected Measure Amount Annual rent increase (as a percent) Operating Leases, Rent Expense, Annual Increase, Percent Operating Leases, Rent Expense, Annual Increase, Percent Investments, Debt and Equity Securities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Current assets: Assets, Current [Abstract] Derivative liability Derivative Liability Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Sales and maturities of investments Proceeds from Sale, Maturity and Collection of Short-Term Investments Income tax expense Income Tax Expense (Benefit) License agreement term Collaborative Arrangement, Termination Notice Collaborative Arrangement, Termination Notice Award Timing Method Award Timing Method [Text Block] Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Service Based Options Service Based Options [Member] Service Based Options [Member] Accrued interest Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss AVTX-501 AVTX-501 [Member] AVTX-501 Net loss Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Milestone One Milestone One [Member] Milestone One [Member] Issuance of common stock pursuant to AlmataBio Milestone Buyout Option (in shares) Stock Issued During Period, Shares, Purchase of Assets Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Upfront payment paid Upfront Payment Paid Upfront Payment Paid Decrease in right of use asset Increase (Decrease) in Right Of Use Asset Increase (Decrease) in Right Of Use Asset Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price RSUs vested during 2025 RSUs vested during 2025 [Member] RSUs vested during 2025 Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Change in fair value of derivative liability Fair Value, Option, Changes in Fair Value, Gain (Loss) Mezzanine equity: Temporary Equity [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]